Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Prevalence and Genetic Diversity of Simian Malaria in Wild Macaque Populations Across Thailand: Implications for Human Health.
Karnchaisri K. et al, (2024), Acta tropica
Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers.
Pukrittayakamee S. et al, (2024), eLife, 12
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Luvira V. et al, (2024), BMC Infectious Diseases, 24
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
Schilling WHK. et al, (2024), The Lancet Infectious Diseases, 24, 36 - 45
Trio fluorophore-based phenotypic assay for the detection of artemisinin-induced growth-arrested Plasmodium falciparum in human erythrocytes.
Kobpornchai P. et al, (2024), Scientific reports, 14
A novel sensitive hexaplex high-resolution melt assay for identification of five human Plasmodium species plus internal control.
Srisutham S. et al, (2023), Acta tropica, 248
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
Jittamala P. et al, (2023), The Journal of Infectious Diseases, 228, 1318 - 1325
Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria
Mukaka M. et al, (2023), eBioMedicine, 96, 104805 - 104805
Limited Polymorphism in the Dihydrofolate Reductase (dhfr) and dihydropteroate synthetase genes (dhps) of Plasmodium knowlesi isolate from Thailand.
Sangsri R. et al, (2023), Acta tropica
Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin-piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia.
Rahmasari FV. et al, (2023), Malaria journal, 22
In vitro activity of rhinacanthin analogues against drug resistant Plasmodium falciparum isolates from Northeast Thailand.
Chaorattanakawee S. et al, (2023), Malar J, 22
Lineage-informative microhaplotypes for spatio-temporal surveillance of Plasmodium vivax malaria parasites.
Siegel SV. et al, (2023), medRxiv
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
Schilling WHK. et al, (2023), eLife, 12
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Odera DO. et al, (2023), Science translational medicine, 15
Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples
Abdel Hamid MM. et al, (2023), Wellcome Open Research, 8, 22 - 22
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial
Tripura R. et al, (2023), The Lancet Infectious Diseases, 23, 81 - 90
Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries
Srisutham S. et al, (2022), PLOS ONE, 17, e0278928 - e0278928
Drug resistance of Plasmodium falciparum and Plasmodium vivax isolates in Indonesia.
Rahmasari FV. et al, (2022), Malaria journal, 21